Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.

Genet Med 2011 Mar;13(3):255-62

Human and Molecular Genetics Center, The Medical College of Wisconsin, Milwaukee 53226, USA.

Purpose: We report a male child who presented at 15 months with perianal abscesses and proctitis, progressing to transmural pancolitis with colocutaneous fistulae, consistent with a Crohn disease-like illness. The age and severity of the presentation suggested an underlying immune defect; however, despite comprehensive clinical evaluation, we were unable to arrive at a definitive diagnosis, thereby restricting clinical management.

Methods: We sought to identify the causative mutation(s) through exome sequencing to provide the necessary additional information required for clinical management.

Results: After sequencing, we identified 16,124 variants. Subsequent analysis identified a novel, hemizygous missense mutation in the X-linked inhibitor of apoptosis gene, substituting a tyrosine for a highly conserved and functionally important cysteine. X-linked inhibitor of apoptosis was not previously associated with Crohn disease but has a central role in the proinflammatory response and bacterial sensing through the NOD signaling pathway. The mutation was confirmed by Sanger sequencing in a licensed clinical laboratory. Functional assays demonstrated an increased susceptibility to activation-induced cell death and defective responsiveness to NOD2 ligands, consistent with loss of normal X-linked inhibitor of apoptosis protein function in apoptosis and NOD2 signaling.

Conclusions: Based on this medical history, genetic and functional data, the child was diagnosed as having an X-linked inhibitor of apoptosis deficiency. Based on this finding, an allogeneic hematopoietic progenitor cell transplant was performed to prevent the development of life-threatening hemophagocytic lymphohistiocytosis, in concordance with the recommended treatment for X-linked inhibitor of apoptosis deficiency. At >42 days posttransplant, the child was able to eat and drink, and there has been no recurrence of gastrointestinal disease, suggesting this mutation also drove the gastrointestinal disease. This report describes the identification of a novel cause of inflammatory bowel disease. Equally importantly, it demonstrates the power of exome sequencing to render a molecular diagnosis in an individual patient in the setting of a novel disease, after all standard diagnoses were exhausted, and illustrates how this technology can be used in a clinical setting.

Download full-text PDF

Source Listing
March 2011
231 Reads

Publication Analysis

Top Keywords

inhibitor apoptosis
x-linked inhibitor
exome sequencing
gastrointestinal disease
apoptosis deficiency
inflammatory bowel
definitive diagnosis
bowel disease
death defective
responsiveness nod2
laboratory functional
cell death
defective responsiveness
activation-induced cell


(Supplied by CrossRef)
Article in Nat Genet
Ng SB et al.
Nat Genet 2010
Article in Nature
Ng SB et al.
Nature 2009
Article in Proc Natl Acad Sci USA
Choi M et al.
Proc Natl Acad Sci USA 2009
Article in Science
Roach JC et al.
Science 2010
Article in Lancet
Ashley EA et al.
Lancet 2010
Article in N Engl J Med
Lupski JR et al.
N Engl J Med 2010
Article in Inflamm Bowel Dis
Lu Y et al.
Inflamm Bowel Dis 2009
Article in Immunol Res
Brodsky RA et al.
Immunol Res 2010
Article in World J Gastroenterol
Yamamoto-Furusho JK et al.
World J Gastroenterol 2007
Article in Inflamm Bowel Dis
Rahman FZ et al.
Inflamm Bowel Dis 2008
Article in Carcinogenesis
Lin HJ et al.
Carcinogenesis 1994

Similar Publications